The Clinical Trial of Application of Methylene Blue Vial for Treatment of Covid-19 Patients (Mashhad, Iran) (2020)

Government Record · Mashhad University of Medical Sciences · April 19, 2020

Mashhad University of Medical Sciences, 2020-04-19: Iranian registry entry for a methylene blue trial in COVID-19 patients (estimated 20 participants) whose status is 'Unknown' , no results and no confirmed completion.

Leucomethylene Blue (reduced form of MB, colorless) may be applied for the treatment of COVID-19 according to the scientific evidences.

Registry record field

Mashhad University of Medical Sciences, 2020-04-19: Iranian registry entry for a methylene blue trial in COVID-19 patients (estimated 20 participants) whose status is 'Unknown' , no results and no confirmed completion. Registry record field from the API v2 record, hence MEDIUM. Status UNKNOWN, enrolment ESTIMATED 20, phase 1. This is the registry predecessor of the Mashhad group's published trials (the 80-patient and 122-patient RCTs are separate citations in this claim). 'Status unknown, no results'. Study type: other.